At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,339 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight (ELBW) Infants
In Brief
An observational study for Infant, Newborn and 6 related conditions. Completed, enrolled 1,339 participants across 15 sites.
Detailed Summary
This study examined the effect of magnesium sulfate (MgSO4) exposure on adverse outcome in extremely low birth weight (ELBW) infants. For infants included in the NICHD Neonatal Research Network Generic Database whose mothers were given prenatal MgSO4, data were prospectively collected on maternal/infant conditions and magnesium exposure (including indications, timing and duration of exposure).
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsInfant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature, Intracranial Hemorrhages, Leukomalacia, Periventricular, Cerebral Palsy
CountriesUnited States
CollaboratorsNational Center for Research Resources (NCRR)
Timeline
N/ACompletedFinished
19961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJul 1996
Primary CompletionJun 1998
Study CompletionJun 2000
First PostedSep 2010
TodayJul 2026
First PostedSep 16, 2010
Enrollment StartJul 1, 1996
Primary CompletionJun 1, 1998
Study CompletionJun 1, 2000
TodayJul 1, 2026
Enrollment to primary: 1.9 yearsPosted 15.8 years ago